Could nitric oxide be an important mediator in opioid tolerance and morphine side effects?

[1]  G. Lauretti,et al.  Double-blind evaluation of transdermal nitroglycerine as adjuvant to oral morphine for cancer pain management. , 2002, Journal of clinical anesthesia.

[2]  K. Okuda,et al.  Characterization of nociceptive responses and spinal releases of nitric oxide metabolites and glutamate evoked by different concentrations of formalin in rats , 2001, Pain.

[3]  I. Duarte,et al.  Activation of ATP-sensitive K(+) channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. , 2000, European journal of pharmacology.

[4]  Andrea M Nolan,et al.  The role of nitric oxide and prostaglandin signaling pathways in spinal nociceptive processing in chronic inflammation , 2000, Pain.

[5]  G. Lauretti,et al.  Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. , 1999, Anesthesiology.

[6]  G. Lauretti,et al.  Transdermal nitroglycerine enhances spinal sufentanil postoperative analgesia following orthopedic surgery. , 1999, Anesthesiology.

[7]  V. Zelman,et al.  Rapid reversal of endothelin-1-induced cerebral vasoconstriction by intrathecal administration of nitric oxide donors. , 1997, Neurosurgery.

[8]  D. Barber.  The physiology and pharmacology of pain: a review of opioids. , 1997, Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses.

[9]  A. Dray.  Peripheral Mediators of Pain , 1997 .

[10]  A. Dickenson,et al.  The Pharmacology of Pain , 1997, Handbook of Experimental Pharmacology.

[11]  A. Morinan.  The physiology and pharmacology of pain , 1996 .

[12]  J. Traynor.  The μ-opioid receptor , 1996 .

[13]  T. Lamer,et al.  Treatment of cancer-related pain: when orally administered medications fail. , 1994, Mayo Clinic proceedings.

[14]  R. Przewłocki,et al.  Inhibition of nitric oxide synthase attenuates the development of morphine tolerance and dependence in mice , 1994, Neuropharmacology.

[15]  M. Zhuo,et al.  Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission , 1993, Pain.

[16]  G. Gebhart,et al.  Nitric oxide (NO) and nociceptive processing in the spinal cord , 1993, Pain.

[17]  S. Ferreira,et al.  The molecular mechanism of central analgesia induced by morphine or carbachol and the L-arginine-nitric oxide-cGMP pathway. , 1992, European journal of pharmacology.